Using PRO Data to Assess Treatment Readiness in Multiple Myeloma

Improved survival in myeloma and demographic shifts call for new approaches to future treatment organization. Empowering patients to manage their own treatment using PRO data can be part of the solution. It proves effective for both younger and older patients, reducing system pressure while maintaining safety.